Skip to main content

Table 1 Patient demographics

From: Safety and effcacy of remimazolam tosilate for sedation during combined spinal-epidural anesthesia for orthopedic procedures: a randomized controlled trial

 

Remimazolam(n = 40) n(%) or mean ± SD

Dexmedetomidine(n = 40) n(%) or mean ± SD

P-value

BMI(kg/m2)

22.72 ± 2.92

23.18 ± 2.91

0.48

Age(years)

58.77 ± 10.67

61.70 ± 12.05

0.25

Sex, n(%)

  

0.30

 Men

14(35.00%)

18(45.00%)

 

 Women

26(65.00%)

22(65.00%)

 

Operation Time(min)

75.90 ± 29.88

77.20 ± 25.03

0.83

ASA status

  

0.87

 I

11(27.50%)

10(25.00%)

 

 II

20(50.00%)

19(47.50%)

 

 III

9(22.50%)

11(27.50%)

 
  1. BMI Body mass index, ASA status American Society of Anesthesiology
  2. Data are count (%), mean (SD)